Your browser doesn't support javascript.
loading
CD4+ T cells expressing CX3CR1, GPR56, with variable CD57 are associated with cardiometabolic diseases in persons with HIV.
Wanjalla, Celestine N; Gabriel, Curtis L; Fuseini, Hubaida; Bailin, Samuel S; Mashayekhi, Mona; Simmons, Joshua; Warren, Christopher M; Glass, David R; Oakes, Jared; Gangula, Rama; Wilfong, Erin; Priest, Stephen; Temu, Tecla; Newell, Evan W; Pakala, Suman; Kalams, Spyros A; Gianella, Sara; Smith, David; Harrison, David G; Mallal, Simon A; Koethe, John R.
Affiliation
  • Wanjalla CN; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Gabriel CL; Division of Gastroenterology, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Fuseini H; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Bailin SS; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Mashayekhi M; Division of Endocrinology, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Simmons J; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Warren CM; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Glass DR; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Oakes J; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Gangula R; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Wilfong E; Division of Rheumatology, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Priest S; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Temu T; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Newell EW; Department of Global Health, University of Washington, Seattle, WA, United States.
  • Pakala S; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Kalams SA; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Gianella S; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Smith D; Department of Medicine, University of California, San Diego, CA, United States.
  • Harrison DG; Department of Medicine, University of California, San Diego, CA, United States.
  • Mallal SA; Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Koethe JR; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
Front Immunol ; 14: 1099356, 2023.
Article in En | MEDLINE | ID: mdl-36865544
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / CD4-Positive T-Lymphocytes / HIV Infections Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / CD4-Positive T-Lymphocytes / HIV Infections Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Country of publication: